acetaminophen
- Product NDC
- 69842-484
- 11-digit product format
- 698420484
- Labeler code
- 69842
- Product ID
- 69842-484_5a9381a8-3dae-4260-8466-cabec7e0274f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CVS Pharmacy
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-12
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 69842-484 | 69842-484-47 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 69842-484 | 69842-484-87 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 69842-484 | 69842-484-90 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 69842-484 | 69842-484-93 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-47 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-90 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-93 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-87 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-87 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-90 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-47 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-93 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-87 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-90 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-47 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-93 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-87 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-90 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-47 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-93 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-87 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-90 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-47 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-93 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-87 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-90 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-47 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-93 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-87 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-90 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-47 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-93 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-87 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-90 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-47 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-93 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-87 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-90 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-47 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-93 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-87 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-90 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-47 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-93 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-87 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-90 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-47 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-93 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-47 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-93 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-87 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-90 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetaminophen
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198440 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fc2d4367-8884-4b76-aa3e-8c35be1ace49 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69842-484-47 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-47 | acetaminophen | 150 in 1 BOTTLE | TABLET | 150 | 6 | |
| 69842-484-62 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-62 | acetaminophen | 24 in 1 BOTTLE | TABLET | 24 | 6 | |
| 69842-484-71 | acetaminophen | 50 in 1 BOTTLE | TABLET | 50 | 6 | |
| 69842-484-71 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-78 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-78 | acetaminophen | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 69842-484-83 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-83 | acetaminophen | 225 in 1 BOTTLE | TABLET | 225 | 6 | |
| 69842-484-87 | acetaminophen | 150 in 1 BOTTLE | TABLET | 150 | 6 | |
| 69842-484-87 | acetaminophen | 2 in 1 CARTON | TABLET | 2 | 6 | |
| 69842-484-90 | acetaminophen | 500 in 1 BOTTLE | TABLET | 500 | 6 | |
| 69842-484-93 | acetaminophen | 1000 in 1 BOTTLE | TABLET | 1000 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69842-484-62 | EA - Each | 69842-484 | 144202f0-c28c-4c01-9a62-8c0d8fa6dbfc | 1 | 2020-02-13 |
| 69842-484-71 | EA - Each | 69842-484 | 6acb8903-d469-4d15-a1db-80a76d63b15a | 1 | 2020-02-13 |
| 69842-484-90 | EA - Each | 69842-484 | 4c3292b2-3b99-4815-9fa5-e579d9b6cf80 | 1 | 2019-06-19 |
| 69842-484-93 | EA - Each | 69842-484 | 001bb4ea-638c-40c1-b701-6c673e4f1415 | 1 | 2020-02-13 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin Regular Strength | ASPIRIN | Rite Aid Corporation | 879e2258-f61b-47ad-a4b1-7d1e78823570 | 2026-03-05 | Warnings | M013 |
| Aspirin | ASPIRIN | ARMY AND AIR FORCE EXCHANGE SERVICE | 87c580d3-6009-4be9-aea7-13539fbe6e31 | 2026-03-05 | Warnings | M013 |
| Aspirin Low Dose Chewable Orange | ASPIRIN | MAJOR PHARMACEUTICALS | fb3a8e38-e991-49c9-93dc-1d29c0a97ba3 | 2026-03-05 | Warnings | M013 |
| Infants Pain and Fever | ACETAMINOPHEN | Kroger | 41e149df-4140-95cc-e063-6294a90a866b | 2026-03-03 | Warnings | M013 |
| Medique Pain Off | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Sportpharm LLC | 2b35acdc-ff88-46e6-a108-5240aac1d53f | 2026-03-03 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | Best Choice (Valu Merchandisers Company) | a8a0d9a5-1a36-4ed2-ae9c-7e1a3d674c07 | 2026-03-03 | Warnings | M013 |
| pain relief | ACETAMINOPHEN | HyVee Inc | 6820a515-4004-407b-969b-c4069dc0c3b5 | 2026-02-26 | Warnings | M013 |
| Acetaminophen, Diphenhydramine Hydrochloride | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | LEADER/ Cardinal Health 110, Inc. | 7be4d67e-1af9-f059-e053-2991aa0a382e | 2026-02-26 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | NCS HealthCare of KY, LLC dba Vangard Labs | f32fc2e9-c0e3-4a25-8399-9cdba6ae8a16 | 2026-02-26 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | NCS HealthCare of KY, LLC dba Vangard Labs | 1f4ac0e6-e986-4c22-8248-0691d64e1a30 | 2026-02-26 | Warnings | M013 |
| Childrens Chewable Acetaminophen | ACETAMINOPHEN | Discount Drug Mart | f413a617-1166-4940-b6ec-fae32238a780 | 2026-02-26 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | NCS HealthCare of KY, LLC dba Vangard Labs | 19735691-33f3-4e19-85ad-e5f270251ec5 | 2026-02-26 | Warnings | M013 |
| Acetaminophen Liquid / Acetaminophen Diphenhydramine HCl Liquid | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Kroger | 44520aa1-b63f-4239-e063-6394a90a5e14 | 2026-02-25 | Warnings | M013 |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 12fd643d-7c60-453f-a81f-407ed20e8725 | 2026-02-25 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | d96a1531-772b-4a5c-89e4-66fff1fa3d78 | 2026-02-25 | Warnings | M013 |
| Gentle Care Kit | ZINC OXIDE | Kenvue Brands LLC | 4b8f7a5a-2fc4-ea00-e063-6294a90ab95b | 2026-02-24 | Warnings | M013 |
| Excedrin PM Triple Action Caplets and Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | 444fa225-c204-45d1-b3b3-aa5650ee5d07 | 2026-02-23 | Warnings | M013 |
| Excedrin Extra Strength and Excedrin Tension Headache | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 2c8df1c7-7864-48df-939c-d9ae22e0f52c | 2026-02-23 | Warnings | M013 |
| Equate Childrens Pain and Fever | ACETAMINOPHEN | Wal-Mart Stores Inc | 40eedfe9-54e1-40a2-b4a2-55ff708b89cd | 2026-02-23 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
| 198440 | APAP 500 MG Oral Tablet | SY | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69842-484-47 | 69842048447 | 1 BOTTLE in 1 CARTON (69842-484-47) > 150 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-62 | 69842048462 | 1 BOTTLE in 1 CARTON (69842-484-62) / 24 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-71 | 69842048471 | 1 BOTTLE in 1 CARTON (69842-484-71) / 50 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-78 | 69842048478 | 1 BOTTLE in 1 CARTON (69842-484-78) / 100 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-83 | 69842048483 | 1 BOTTLE in 1 CARTON (69842-484-83) / 225 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-87 | 69842048487 | 2 BOTTLE in 1 CARTON (69842-484-87) > 150 TABLET in 1 BOTTLE | 2 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-90 | 69842048490 | 500 TABLET in 1 BOTTLE (69842-484-90) | 500 tablet | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-93 | 69842048493 | 1000 TABLET in 1 BOTTLE (69842-484-93) | 1000 tablet | 2018-06-12 | 0000-00-00 | No | No | Current |